by aporter@parthenonmgmt.com | Aug 25, 2025 | Clinical Pharmacology
The process of testing, developing and marketing of medicines has to regulated to protect the interests of the public. Major regulatory bodies include the Food & Drug Administration (FDA) in the US and the European Medicines Agency (EMA) in Europe. These bodies...
by aporter@parthenonmgmt.com | Aug 25, 2025 | Clinical Pharmacology
A clinical trial involves the testing of a new medicine (or other therapy) to evaluate whether it is effective and safe. Clinical trials of drugs can be divided into those assessing the treatment of a disease (e.g. asthma) or those assessing treatments to prevent the...
by aporter@parthenonmgmt.com | Aug 22, 2025 | Clinical Pharmacology
When a new drug has been discovered it goes through a development process that aims to deliver sufficient evidence for it to be granted a marketing authorisation (‘license’) by the relevant regulatory authority. This process takes over 10 years and may cost up to...
by aporter@parthenonmgmt.com | Aug 22, 2025 | Clinical Pharmacology
A medication error is any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional or patient. A prescribing error is a medication error related to an error in...
by aporter@parthenonmgmt.com | Aug 22, 2025 | Clinical Pharmacology
A drug interaction has occurred when the administration of one drug alters the clinical effects of another. The result may be an increase or decrease in either the beneficial or harmful effects of the second agent. Although the number of potential interacting drug...
